XAIRHealthcare · Medical DevicesThe 1 Wall Street analysts covering Beyond Air, Inc. hold a median 12-month price target of $30 — +375.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 39 of 100 as at 15 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Beyond Air, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (95): Smaller than most of the companies we track.
Issuance (3): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on XAIR, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
The green dot is the last close — the median target sits +375.1% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 27 Mar 2026 | D. Boral Capital | Maintains | Buy | $10 |
| 18 Mar 2026 | D. Boral Capital | Maintains | Buy | — |
| 10 Mar 2026 | D. Boral Capital | Maintains | Buy | — |
| 21 Jan 2026 | D. Boral Capital | Maintains | Buy | — |
| 11 Nov 2025 | D. Boral Capital | Maintains | Buy | — |
| 21 Aug 2025 | D. Boral Capital | Maintains | Buy | — |
| 13 Aug 2025 | D. Boral Capital | Maintains | Buy | — |
| 17 July 2025 | D. Boral Capital | Initiates | Buy | — |
| 16 Aug 2024 | Roth MKM | Reinstates | Buy | $2.00 |
| 7 Aug 2024 | Piper Sandler | Maintains | Overweight | — |
| 25 June 2024 | BTIG | Downgrade | Neutral | — |
| 25 June 2024 | Piper Sandler | Maintains | Overweight | — |
| 30 Apr 2024 | Truist Securities | Maintains | Buy | — |
| 14 Nov 2023 | Truist Securities | Maintains | Buy | — |
| 28 July 2023 | Piper Sandler | Initiates | Overweight | — |
| 21 July 2023 | Truist Securities | Maintains | Buy | — |
| 23 June 2023 | Oppenheimer | Maintains | Outperform | — |
| 15 June 2023 | BTIG | Initiates | Buy | — |
| 29 June 2022 | Ladenburg Thalmann | Maintains | Buy | — |
| 29 June 2022 | Truist Securities | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. XAIR appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 77% of US stocks
Cheaper than 77% of US stocks
Cheaper than 83% of US stocks
Cheaper than 65% of US stocks
Higher than 90% of US stocks
Higher than 79% of US stocks
Higher than 6% of US stocks
Higher than 8% of US stocks
Higher than 56% of US stocks
Higher than 4% of US stocks
Higher than 7% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Beyond Air, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Beyond Air, Inc. held its Q1 2027 earnings call, which was transcribed by Seeking Alpha.
Why it matters — Earnings calls provide investors and analysts with management's perspective on quarterly financial results and operational progress.
Beyond Air, Inc. reported financial results for the quarter ended June 30, 2026, with $1.8 million in revenue, and reaffirmed its revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027.
Why it matters — The reported revenue and reaffirmed full-year guidance provide a baseline for XAIR watchers tracking the company's financial trajectory for 2026 and 2027.
Beyond Air, Inc. announced it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026, and that its management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time the same day.
Why it matters — Investors watching XAIR would care because this sets the date for the company's next scheduled update on its quarterly financial results.
Beyond Air announced it has entered into a securities purchase agreement for a private placement offering of up to $30.1 million, involving shares of common stock and warrants sold to institutional investors as well as the company's directors and officers, priced at-the-market under Nasdaq rules.
Why it matters — A XAIR watcher would care because this capital raise through a private placement with both institutional investors and insider participation could affect the company's financial position and share structure.
The 1 Wall Street analysts covering Beyond Air, Inc. have a median 12-month price target of $30, with estimates ranging from $30 to $30. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 1 analysts covering Beyond Air, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Beyond Air, Inc. 39 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 15 Aug 2026, Beyond Air, Inc. ranks 39 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (95 of 100).
No one can know that. What the data says: the median 12-month target from 1 analysts implies +375.1% from the last close, and Ticker Nerd's factor model ranks Beyond Air, Inc. 39 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Beyond Air, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XAIR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $30 to $30 over the next 12 months.
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company specializing in nitric oxide therapy.
The most recent item we track (Seeking Alpha, 13 Aug 2026): "Beyond Air, Inc. (XAIR) Q1 2027 Earnings Call Transcript". Beyond Air, Inc. held its Q1 2027 earnings call, which was transcribed by Seeking Alpha.
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company specializing in nitric oxide therapy. Central to its offerings is the LungFit platform, an innovative nitric oxide generator and delivery system that uses patented Ionizer™ technology to produce unlimited, on-demand nitric oxide from ambient air, eliminating the need for traditional gas cylinders. The company’s product range includes LungFit PH for treating persistent pulmonary hypertension in newborns, LungFit PRO targeting viral lung infections like pneumonia and COVID-19, and LungFit GO for at-home treatment of nontuberculous mycobacteria infections. Beyond Air also develops therapeutics such as ultra-high concentration nitric oxide treatments for solid tumors and selective neuronal nitric oxide synthase inhibitors for neurological conditions including autism spectrum disorder. With a commitment to advancing respiratory and neurological healthcare, Beyond Air leverages its innovative technologies to expand treatment options across hospital and home settings, driven by a leadership team with deep clinical and scientific expertise.
CEO Mr. Steven Adam Lisi · 61 employees · United States · https://www.beyondair.net